Aurobindo Pharma Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
64746.22 Cr.
|
P/BV
|
2.41
|
Book Value (Rs.)
|
458.07
|
52 Week High/Low (Rs.)
|
1177/581
|
FV/ML
|
1/1
|
P/E(X)
|
33.59
|
Bookclosure
|
20/02/2024
|
EPS (Rs.)
|
32.90
|
Div Yield (%)
|
0.27
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
No. of Equity Shares (in Lacs) | 5859.39 | 5859.39 | 5859.39 | 5859.39 | 5859.16 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 |
Total Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 |
| | | | | |
Reserves and Surplus | 26781.26 | 24517.39 | 21871.28 | 16751.79 | 13832.13 |
Total Reserves and Surplus | 26781.26 | 24517.39 | 21871.28 | 16751.79 | 13832.13 |
Employees Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 |
Total Shareholders Funds | 26839.85 | 24575.98 | 21929.87 | 16810.38 | 13890.78 |
Minority Interest | 12.00 | -1.93 | -0.88 | 0.14 | 1.59 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Long Term Borrowings | 618.96 | 249.21 | 168.40 | 0.00 | 179.95 |
Deferred Tax Liabilities [Net] | 389.61 | 410.96 | 574.56 | 302.48 | 281.31 |
Other Long Term Liabilities | 363.07 | 359.73 | 359.78 | 351.89 | 33.62 |
Long Term Provisions | 172.72 | 171.79 | 157.11 | 74.71 | 46.54 |
Total Non-Current Liabilities | 1544.36 | 1191.69 | 1259.85 | 729.08 | 541.42 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 4242.56 | 2123.56 | 4802.71 | 5422.30 | 6573.21 |
Trade Payables | 3871.31 | 2703.05 | 2794.68 | 2545.01 | 2552.18 |
Other Current Liabilities | 3179.38 | 3158.81 | 2895.83 | 3002.80 | 2576.78 |
Short Term Provisions | 200.53 | 170.56 | 171.93 | 416.64 | 318.40 |
Total Current Liabilities | 11493.78 | 8155.98 | 10665.15 | 11386.75 | 12020.57 |
| | | | | |
Total Capital And Liabilities | 39889.99 | 33921.72 | 33853.99 | 28926.35 | 26454.36 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 7995.38 | 7728.44 | 6886.62 | 6494.81 | 5693.65 |
Intangible Assets | 2432.24 | 2328.23 | 2058.06 | 1985.72 | 1948.69 |
Capital Work-In-Progress | 4496.40 | 2937.56 | 2428.89 | 1621.82 | 1341.94 |
Intangible Assets Under Development | 893.61 | 809.64 | 632.64 | 364.12 | 326.52 |
Fixed Assets | 15817.63 | 13803.87 | 12006.21 | 10466.47 | 9310.80 |
Goodwill On Consolidation | 596.07 | 475.42 | 428.90 | 915.94 | 832.51 |
Non-Current Investments | 391.74 | 618.30 | 431.22 | 554.69 | 360.20 |
Deferred Tax Assets [Net] | 677.49 | 288.59 | 452.68 | 163.20 | 183.29 |
Long Term Loans And Advances | 5.57 | 6.32 | 7.26 | 5.84 | 6.46 |
Other Non-Current Assets | 855.82 | 606.53 | 704.21 | 407.71 | 428.80 |
Total Non-Current Assets | 18344.32 | 15799.03 | 14030.48 | 12513.85 | 11122.06 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Current Investments | 151.00 | 378.85 | 159.79 | 0.02 | 0.02 |
Inventories | 8511.23 | 7553.85 | 9026.57 | 7699.87 | 7245.60 |
Trade Receivables | 4466.38 | 4012.26 | 3503.28 | 4315.15 | 3413.78 |
Cash And Cash Equivalents | 6084.20 | 4190.01 | 5474.28 | 2842.15 | 1957.18 |
Short Term Loans And Advances | 12.43 | 12.71 | 14.32 | 13.68 | 10.26 |
OtherCurrentAssets | 2320.43 | 1975.01 | 1645.27 | 1541.63 | 2705.46 |
Total Current Assets | 21545.67 | 18122.69 | 19823.51 | 16412.50 | 15332.30 |
| | | | | |
Total Assets | 39889.99 | 33921.72 | 33853.99 | 28926.35 | 26454.36 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 1813.21 | 1145.45 | 1083.17 | 659.39 | 688.84 |
| | | | | |
BONUS DETAILS | | | | | |
Bonus Equity Share Capital | 46.55 | 46.55 | 46.55 | 46.55 | 46.55 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Quoted Market Value | 208.23 | 317.59 | 154.00 | 0.00 | 0.00 |
Non-Current Investments Unquoted Book Value | 93.51 | 221.36 | 182.52 | 145.08 | 112.64 |
| | | | | |
CURRENT INVESTMENTS | | | | | |
Current Investments Quoted Market Value | 81.87 | 378.85 | 0.77 | 0.02 | 0.02 |
Current Investments Unquoted Book Value | 0.00 | 0.70 | 159.72 | 0.00 | 0.00 |